Immunohistochemical assessment of cyclin D1 and p53 is associated with survival in childhood malignant peripheral nerve sheath tumor-Reference-Cited by-同舟云学术

Immunohistochemical assessment of cyclin D1 and p53 is associated with survival in childhood malignant peripheral nerve sheath tumor

Published:2019-04-03 Issue:3 Volume:24 Page:351-361
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Krawczyk Malgorzata A.¹¹,Karpinsky Gabrielle²¹,Izycka-Swieszewska Ewa³,Gabrych Anna⁴,Kunc Michal⁵,Fatyga Aleksandra⁴,Garstka Monika⁶,Styczewska Malgorzata⁶,Sokolewicz Ewa M.⁶,Szlagatys-Sidorkiewicz Agnieszka⁷,Kazanowska Bernarda⁶,Bien Ewa¹

Affiliation:

1. Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk, Gdansk, Poland

2. Children’s Hospital of Michigan, Detroit, MI, USA

3. Department of Pathology and Neuropathology, Medical University of Gdansk, Gdansk, Poland

4. Department of Pediatrics, Hematology and Oncology, University Clinical Centre, Gdansk, Poland

5. Department of Pathomorphology, Medical University of Gdansk, Gdansk, Poland

6. The English Division Pediatric Oncology Scientific Circle, Medical University of Gdansk, Gdansk, Poland

7. Department of Pediatrics, Gastroenterology, Hepatology and Nutrition, Medical University of Gdansk, Gdansk, Poland

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference37 articles.

1. W. Zhou, X. Du, F. Song, H. Zheng, K. Chen, W. Zhang and J. Yang, Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor, Oncotarget 7 (2016).

2. Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours;Thomas;Hum. Genomics,2015

3. Malignant peripheral nerve sheath tumors state of the science: leveraging clinical and biological insights into effective therapies;Kim;Sarcoma,2017

4. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST);Alaggio;PLoS One,2013

5. Survival in malignant peripheral nerve sheath tumours: A comparison between sporadic and neurofibromatosis type 1-associated tumours;Porter;Sarcoma,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant peripheral nerve sheath tumor — from genetics to multidisciplinary treatment;Oncology in Clinical Practice;2024-02-27

2. Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges;JCO Precision Oncology;2022-05

3. The clinical course and role of surgery in pediatric malignant peripheral nerve sheath tumors: a database study;Journal of Neurosurgery: Pediatrics;2022-01-01

4. High Expression of Solute Carrier Family 2 Member 1 (SLC2A1) in Cancer Cells Is an Independent Unfavorable Prognostic Factor in Pediatric Malignant Peripheral Nerve Sheath Tumor;Diagnostics;2021-03-26

5. Prognostic Significance of Immunohistochemical Markers and Genetic Alterations in Malignant Peripheral Nerve Sheath Tumors: A Systematic Review;Frontiers in Oncology;2020-12-22